Transforming Cognitive Heath conditions through Clinical Games

Abstract: As clinical games emerge as a new tool for diagnosing and treating cognitive health, it is important to understand how these tools work and the ways in which these tools are validated, as well as their full potential. The FDA started watching this trend in 2007, and in 2013 released new guidelines surrounding the use of medically relevant software. According to the FDA, when a stand-alone software is used to analyze medical device data, it has traditionally been regulated as an accessory to a medical device or as medical device software. Following this, more clinical trials were conducted centering on video games. Approximately 35% of the studies involving impact of gaming on cognitive heath was aimed at nervous system diseases such as Alzheimer?s, Parkinson?s etc. The observation of such studies was seen to be largely conducted by universities and research institutes. A very prominent feature of such applications is continuous usage of such apps over the trial period would boost adherence by 25- 35% leading to increased utilisation of such apps by pharmaceutical companies. In 2014, a new trend emerged when a large pharmaceutical company forged a partnership with a gaming company to use a particular game as a biomarker in their trial conduct.